On September 10, 2013 at the Intel Developer Forum, Intel President Renée James highlighted the growth of connected, personalized healthcare and the merge of healthcare and computation. Human genome, which holds the key to personalized medicine, usually takes a long time to calculate and is very expensive. But the new high-speed computing power from Intel will help make personalized medicine more accessible and affordable.


Separately, Greg Caressi, senior VP, Healthcare & Life Sciences, Frost & Sullivan, in their 18th annual Medical Devices, 2013 meeting, discussed personalized medicine and the shortage and changing role of primary care physicians.